Literature DB >> 26628259

[Modern magnetic resonance imaging of the liver].

D M Hedderich1, K Weiss1,2, D Maintz1, T Persigehl3.   

Abstract

Magnetic resonance imaging (MRI) of the liver has become an essential tool in the radiological diagnostics of both focal and diffuse diseases of the liver and is subject to constant change due to technological progress. Recently, important improvements could be achieved by innovations regarding MR hardware, sequences and postprocessing methods. The diagnostic spectrum of MRI could be broadened particularly due to new examination sequences, while at the same time scanning time could be shortened and image quality has been improved. The aim of this article is to explain both the technological background and the clinical application of recent MR sequence developments and to present the scope of a modern MRI protocol for the liver.

Entities:  

Keywords:  Diffuse liver diseases; Examination sequences; Focal liver diseases; Magnetic resonance imaging; Protocol

Mesh:

Year:  2015        PMID: 26628259     DOI: 10.1007/s00117-015-0031-4

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  55 in total

1.  Generalized autocalibrating partially parallel acquisitions (GRAPPA).

Authors:  Mark A Griswold; Peter M Jakob; Robin M Heidemann; Mathias Nittka; Vladimir Jellus; Jianmin Wang; Berthold Kiefer; Axel Haase
Journal:  Magn Reson Med       Date:  2002-06       Impact factor: 4.668

Review 2.  MR cholangiopancreatography of the pancreas and biliary system: a review of the current applications.

Authors:  Sandy Hassan Hossary; Ashraf Anas Zytoon; Mohamed Eid; Ahmed Hamed; Mohamed Sharaan; Ahmed Abd El-Maguid Ebrahim
Journal:  Curr Probl Diagn Radiol       Date:  2014 Jan-Feb

Review 3.  Diffusion-weighted MR imaging of the liver.

Authors:  Bachir Taouli; Dow-Mu Koh
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

4.  Contrast-enhanced timing robust acquisition order with a preparation of the longitudinal signal component (CENTRA plus) for 3D contrast-enhanced abdominal imaging.

Authors:  Gabriele M Beck; Jan De Becker; Alun C Jones; Marcus von Falkenhausen; Winfried A Willinek; Jürgen Gieseke
Journal:  J Magn Reson Imaging       Date:  2008-06       Impact factor: 4.813

5.  MR relaxometry in chronic liver diseases: Comparison of T1 mapping, T2 mapping, and diffusion-weighted imaging for assessing cirrhosis diagnosis and severity.

Authors:  Christophe Cassinotto; Matthieu Feldis; Julien Vergniol; Amaury Mouries; Hubert Cochet; Bruno Lapuyade; Arnaud Hocquelet; Etienne Juanola; Juliette Foucher; François Laurent; Victor De Ledinghen
Journal:  Eur J Radiol       Date:  2015-05-19       Impact factor: 3.528

6.  Clinical application of controlled aliasing in parallel imaging results in a higher acceleration (CAIPIRINHA)-volumetric interpolated breathhold (VIBE) sequence for gadoxetic acid-enhanced liver MR imaging.

Authors:  Mi Hye Yu; Jeong Min Lee; Jeong-Hee Yoon; Berthold Kiefer; Joon Koo Han; Byung-Ihn Choi
Journal:  J Magn Reson Imaging       Date:  2013-04-04       Impact factor: 4.813

Review 7.  Chemical shift encoding-based water-fat separation methods.

Authors:  Holger Eggers; Peter Börnert
Journal:  J Magn Reson Imaging       Date:  2014-01-21       Impact factor: 4.813

8.  Timing of the hepatic arterial phase at Gd-EOB-DTPA-enhanced hepatic dynamic MRI: comparison of the test-injection and the fixed-time delay method.

Authors:  Shinichi Nakamura; Takeshi Nakaura; Masafumi Kidoh; Daisuke Utsunomiya; Yasuro Doi; Kazunori Harada; Shozaburou Uemura; Yasuyuki Yamashita
Journal:  J Magn Reson Imaging       Date:  2013-06-06       Impact factor: 4.813

9.  Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI.

Authors:  Russell N Low; Jonathan Gurney
Journal:  J Magn Reson Imaging       Date:  2007-04       Impact factor: 4.813

10.  Liver iron overload assessment by MRI R2* relaxometry in highly transfused pediatric patients: an agreement and reproducibility study.

Authors:  S Verlhac; M Morel; F Bernaudin; S Béchet; C Jung; M Vasile
Journal:  Diagn Interv Imaging       Date:  2014-12-19       Impact factor: 4.026

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.